Primary Job Title MD, Co-founder, Chief Medical Officer Primary Organization 
Imagen Biotech
Location Rockville, Maryland, United States Regions Washington DC Metro Area, East Coast, Southern US Gender Male
Matthew Feinsod, MD, was SVP of Strategy and Product Development at Eyetech Pharmaceuticals where he spent five years in a variety of functions helping to develop Macugen and preclinical programs. Prior to joining Eyetech, Matt served as medical officer at the U.S. Food & Drug Administration (FDA), Division of Anti-inflammatory, Analgesic and
Ophthalmologic Drug Products. There, he was a primary reviewer for both IND and NDA ophthalmology applications. Concurrently, he held a clinical trials/drug development fellowship position in George Washington University's Department of Ophthalmology and served on the hospital's Institutional Review Board. Previously, Matt conducted post-doctoral molecular biology research with a focus on nucleotide science at Cornell University Medical Center.
Matt received his MD from the George Washington University School of Medicine and his undergraduate degree from the Wharton School of Business. He completed his residency at the Manhattan Eye, Ear and Throat Hospital and is board-certified in ophthalmology. Matt holds several patents in the field of ophthalmology and in emitted light-stabilization. He is founder of Transmedical Corporation, a medical publishing/marketing company, and co-founder of Gyrotech LLC, developer of light-stabilization technology.
